Clinical Trials Logo
  1. Home
  2. Fatty Liver, Nonalcoholic
  3. NCT04452409

Enhanced Liver Function in Non-alcoholic Obese Fatty Liver Patients by Low Level Laser Therapy

Fatty Liver, Nonalcoholic Clinical Trial

Official title:
Enhanced Liver Function in Non-alcoholic Obese Fatty Liver Patients by Low Level Laser Therapy

Clinical Trial Summary

Non-alcoholic fatty liver disease is excessive fat build-up in the liver with insulin resistance due to causes other than alcohol use.The obesity epidemic is closely associated with the rising prevalence and severity of nonalcoholic fatty liver disease.Currently, the only treatment modality for patients with fatty liver disease is weight loss and exercise which is challenging for most patients. Therefore, a huge need exists for an alternative approach to reducing alanine transaminase (ALT) & aspartate aminotransferase (AST) levels for these patients. Low level laser light therapy (LLLT) offers a simple, non-invasive, safe, effective and side-effect free alternative to achieving this goal, through LLLT's proven ability to effect weight loss, body circumference reduction and lipid profile modification

Clinical Trial Description

Non-alcoholic fatty liver disease (NAFLD) is a very common disorder and refers to a group of conditions where there is accumulation of excess fat in the liver of people who drink little or no alcohol. The most common form of NAFLD is a non serious condition called fatty liver. NAFLD is part of the metabolic syndrome characterized by diabetes, or pre-diabetes (insulin resistance), being overweight or obese, elevated blood lipids such as cholesterol and triglycerides, as well as high blood pressure. A few studies have suggested that weight loss may be associated with regression of fat within the liver. Therefore, the most important recommendations for people with fatty liver are to lose weight if they are overweight or obese, increase their physical activity, follow a balanced diet and unnecessary medications. Several studies have investigated low-level laser therapy (LLLT) or light-emitting diode (LED) therapy and have made advances in the understanding of the underlying mechanisms LLLT in biological systems. Few studies explain the effect of low level laser therapy on liver enzymes and non alcoholic fatty liver risk factors (as obesity).So, our goal was to perform a randomized controlled trial to investigate the effects of the LLLT on lipid profile, body weight and liver enzymes ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04452409
Study type Interventional
Source Cairo University
Contact
Status Completed
Phase N/A
Start date January 10, 2020
Completion date September 1, 2021
View Details
See also
  Status Clinical Trial Phase
Completed NCT03319199 - The Effect of Combination Therapy Amino Acid L-CARNITINE and Magnesium on Fatty Liver N/A
Recruiting NCT05220956 - Impact of Time-restricted Feeding in NAFLD N/A
Active, not recruiting NCT04067440 - Characterization of the Microbiome in Peritoneum, Jejunum, Rectum and Stool
Completed NCT04509245 - The Effects of a Novel Lifestyle Intervention Program on Insulin Sensitivity in Type 2 Diabetes N/A
Completed NCT03656744 - A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM) Phase 2
Not yet recruiting NCT06117137 - The Impact Of SGLT2 -I on Metabolic Dysfunction -Associated Steatotic Liver Disease In Patients With Type 2 Diabetes Mellitus Phase 3
Completed NCT02132780 - Autonomic Dysfunction in Non-Alcoholic Fatty Liver Disease N/A
Active, not recruiting NCT04241575 - Identification of Fatty Liver With Advanced Fibrosis in Type 2 Diabetes Using Simple Fibrosis Scores and Electronic Reminder Messages N/A
Completed NCT02290106 - Effects of Pitavastatin on Insulin Sensitivity and Liver Fat N/A
Completed NCT03784716 - Ketogenic Diet in Non-alcoholic Fatty Liver Disease N/A
Recruiting NCT05558592 - Evaluation of the Effects of Orange Consumption on Carbohydrate and Lipid Metabolism in Subjects With MAFLD (Metabolic Associated Fatty Liver Disease) N/A
Active, not recruiting NCT06445335 - Prevalence of NAFLD in T2DM Patients N/A
Active, not recruiting NCT05855239 - Quantification of Hepatic Steatosis With Different Ultrasound Frequency
Recruiting NCT05877547 - A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013) Phase 2
Completed NCT04462562 - Quantitative US for Evaluation of Hepatic Steatosis in NAFLD N/A
Completed NCT04054297 - Glycemic Index/Saturated Fatty Acid Diet and Hepatic Fat N/A
Completed NCT03260543 - Efficacy and Safety of Fermented Ginseng Powder on Liver Function N/A
Not yet recruiting NCT06215131 - Feasibility of Immersive Virtual Reality Dietician Program in Metabolic-dysfunction Associated Steatotic Liver Disease N/A
Completed NCT03593343 - Hepatic Glycogen and Fat Oxidation N/A
Recruiting NCT06257732 - Different Exercise Modalities in the Treatment of NAFLD and Their Impact on Myokines N/A